Programme

Lecture Theatre 1A
2021-09-04
09:00-10:30
CRC: prevention is better than cure
09:00
Should routine CRC screening start at 45: latest Recommendations
09:30
Novel non-invasive markers for colorectal cancer and adenoma detection
10:00
Chemoprevention of CRC: what should you tell your patient
Lecture Theatre 1A
2021-09-04
11:00-12:30
Prime time microbiome therapeutics
11:00
Microbiome restoration therapy in C. difficile infection: new clinical trial data
11:30
Fecal microbiota transplantation for C. difficile infections in Hong Kong: territory-wide clinical application
12:00
FMT for indications other than C. difficile: the Nanjing experience
Lecture Theatre 1A
2021-09-04
16:10-17:40
New kids on the block in IBD
16:10
New molecules treatment ready for clinical use
16:40
Emerging role of diet in inflammatory bowel disease management
17:10
Choosing and positioning therapies for ulcerative colitis
Lecture Theatre 1A
2021-09-04
17:40-18:40
COVID-19 has GUTS
17:40
Gut and COVID-19: evolving lessons
18:00
Do IBD drugs impact COVID-19 vaccine?
18:20
Gut microbiome modulation and COVID-19
Lecture Theatre 1A
2021-09-05
14:50-16:20
Update in gastrointestinal disorders
14:50
Advance in GI motility disorders
15:20
Updates in H. Pylori
15:50
GI risk, CVS risk and anticoagulants: double edge sword
CRC: prevention is better than cure
Lecture Theatre 1A
2021-09-04
09:00
09:00
Should routine CRC screening start at 45: latest Recommendations
09:30
Novel non-invasive markers for colorectal cancer and adenoma detection
10:00
Chemoprevention of CRC: what should you tell your patient
Prime time microbiome therapeutics
Lecture Theatre 1A
2021-09-04
11:00
11:00
Microbiome restoration therapy in C. difficile infection: new clinical trial data
11:30
Fecal microbiota transplantation for C. difficile infections in Hong Kong: territory-wide clinical application
12:00
FMT for indications other than C. difficile: the Nanjing experience
New kids on the block in IBD
Lecture Theatre 1A
2021-09-04
16:10
16:10
New molecules treatment ready for clinical use
16:40
Emerging role of diet in inflammatory bowel disease management
17:10
Choosing and positioning therapies for ulcerative colitis
COVID-19 has GUTS
Lecture Theatre 1A
2021-09-04
17:40
17:40
Gut and COVID-19: evolving lessons
18:00
Do IBD drugs impact COVID-19 vaccine?
18:20
Gut microbiome modulation and COVID-19
Update in gastrointestinal disorders
Lecture Theatre 1A
2021-09-05
14:50
14:50
Advance in GI motility disorders
15:20
Updates in H. Pylori
15:50
GI risk, CVS risk and anticoagulants: double edge sword